[Cutaneous side effects of biologics: an important topic also in occupational dermatology].

Authors

Angel Peev, Maurice Waitek, Tatevik Martirosyan, Petra Roll, Elke Weisshaar

Published in

Dermatologie (Heidelberg, Germany). Jul 22, 2026. Epub Jul 22, 2026.

Abstract

A 42-year-old machinist suffered from ankylosing spondylitis since 2009. This had been treated with adalimumab 40 mg subcutaneous (s.c.) every two weeks since 2021. Approximately four years later, he developed erythema and pustules on his palms and soles of the feet. Palmoplantar pustular psoriasis and psoriasis vulgaris were diagnosed. His treatment was changed to secukinumab 150 mg s.c. every four weeks and his skin condition improved slightly. This case demonstrates the importance of considering adverse reactions to biologics in refractory palmoplantar psoriasis, even after years of treatment.

PMID:
42484658
Bibliographic data and abstract were imported from PubMed on 22 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.